Acebutolol HClCAS# 34381-68-5 |
- Etifoxine
Catalog No.:BCC1560
CAS No.:21715-46-8
- Etomidate
Catalog No.:BCC1150
CAS No.:33125-97-2
- Etifoxine hydrochloride
Catalog No.:BCC1561
CAS No.:56776-32-0
- Flumazenil
Catalog No.:BCC1259
CAS No.:78755-81-4
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 34381-68-5 | SDF | Download SDF |
| PubChem ID | 441307 | Appearance | Powder |
| Formula | C18H29ClN2O4 | M.Wt | 372.89 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | DMSO : 100 mg/mL (268.18 mM; Need ultrasonic) H2O : ≥ 50 mg/mL (134.09 mM) *"≥" means soluble, but saturation unknown. | ||
| Chemical Name | N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide;hydrochloride | ||
| SMILES | CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl | ||
| Standard InChIKey | KTUFKADDDORSSI-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C18H28N2O4.ClH/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3;/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23);1H | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Acebutolol HCl Dilution Calculator
Acebutolol HCl Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.6818 mL | 13.4088 mL | 26.8176 mL | 53.6351 mL | 67.0439 mL |
| 5 mM | 0.5364 mL | 2.6818 mL | 5.3635 mL | 10.727 mL | 13.4088 mL |
| 10 mM | 0.2682 mL | 1.3409 mL | 2.6818 mL | 5.3635 mL | 6.7044 mL |
| 50 mM | 0.0536 mL | 0.2682 mL | 0.5364 mL | 1.0727 mL | 1.3409 mL |
| 100 mM | 0.0268 mL | 0.1341 mL | 0.2682 mL | 0.5364 mL | 0.6704 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Acebutolol is a β-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias.
- CP-673451
Catalog No.:BCC4981
CAS No.:343787-29-1
- Ginsenoside Ro
Catalog No.:BCN5937
CAS No.:34367-04-9
- Isoapetalic acid
Catalog No.:BCN5276
CAS No.:34366-34-2
- NS 3623
Catalog No.:BCC6190
CAS No.:343630-41-1
- NSC697923
Catalog No.:BCC4000
CAS No.:343351-67-7
- Cirsiliol
Catalog No.:BCN6822
CAS No.:34334-69-5
- Benzyl 2,6-dimethoxybenzoate
Catalog No.:BCN3697
CAS No.:34328-54-6
- OXA (17-33)
Catalog No.:BCC6364
CAS No.:343268-91-7
- TCS PrP Inhibitor 13
Catalog No.:BCC5999
CAS No.:34320-83-7
- Chelerythrine
Catalog No.:BCN5275
CAS No.:34316-15-9
- Boc-Abu-OH.DCHA
Catalog No.:BCC3200
CAS No.:27494-48-0
- 2,16-Kauranediol
Catalog No.:BCN5274
CAS No.:34302-37-9
- Isovallesiachotamine
Catalog No.:BCN3549
CAS No.:34384-71-9
- N-Demethyl-alpha-obscurine
Catalog No.:BCN7362
CAS No.:34399-44-5
- H-D-Pro-OH
Catalog No.:BCC3023
CAS No.:344-25-2
- Betamipron
Catalog No.:BCC8876
CAS No.:3440-28-6
- Boc-D-Glu-OBzl
Catalog No.:BCC3394
CAS No.:34404-30-3
- H-D-Lys(Z)-OH
Catalog No.:BCC2678
CAS No.:34404-32-5
- Boc-Lys(Z)-OSu
Catalog No.:BCC3418
CAS No.:34404-36-9
- 8-Chloroadenosine
Catalog No.:BCC7935
CAS No.:34408-14-5
- Lathyrol
Catalog No.:BCN4963
CAS No.:34420-19-4
- 2,3-dihydrosciadopitysin
Catalog No.:BCN4034
CAS No.:34421-19-7
- Lyoniside
Catalog No.:BCN5277
CAS No.:34425-25-7
- Ikshusterol
Catalog No.:BCN5278
CAS No.:34427-61-7
The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).[Pubmed:7248475]
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):103-14.
The pharmacokinetics of acebutolol have been studied in eight healthy male volunteers following the oral administration of acebutolol hydrochloride ('Sectral', May & Baker) as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d. for 56 days). Following single dose administration, considerable inter-subject variation in plasma levels of parent drug and the major metabolite, diacetolol, was evident. Acebutolol appeared to be eliminated from plasma in a bi-phasic manner, and this was confirmed from urinary excretion rate data. Mean initial and terminal half-lives of about 2 and 11 h, respectively, were determined. Plasma levels of diacetolol were greater than those of parent drug from 3 to 4 h following dose administration. Total urinary excretion of diacetolol was generally greater than that of acebutolol. During repeated dosing, steady-state plasma levels of acebutolol and diacetolol were achieved in 6 volunteers. Acebutolol did not appear to stimulate or inhibit its metabolism.
First derivative spectrophotometric, TLC-densitometric, and HPLC determination of acebutolol HCL in presence of its acid-induced degradation product.[Pubmed:11272308]
J Pharm Biomed Anal. 2001 Feb;24(4):527-34.
Three methods are presented for the determination of Acebutolol HCl in presence of its acid-induced degradation product. The first method was based on measurement of the first derivative amplitude of Acebutolol HCl at 266.6 nm. The second method was based on separation of Acebutolol HCl from its acid-induced degradation product followed by densitometric measurement of the spots at 230 nm. The separation was carried out on silica gel 60 F254, using ethanol-glacial acetic acid (4:1, v/v) as mobile phase. Second order polynomial equation was used for the regression line. The third method was based on high performance liquid chromatographic (HPLC) separation of Acebutolol HCl from its acid-induced degradation product on a reversed phase, ODS column using a mobile phase of methanol-water (55:45, v/v) with UV detection at 240 nm. The first derivative spectrophotometric method was utilized to investigate the kinetics of the acid degradation process at different temperatures.
